Cardiac Wire #410 October 22, 2026
AI for HF Frailty, FDA Approvals Galore, and Jupiter’s Vertex
Cardiac Wire #409 October 19, 2026
Cardiac Comp Soars, EXIT-CVD, and PCI Timing
Cardiac Wire #408 October 15, 2026
SAPIEN M3 for MAC, HF in Young Adults, and Siemens CVUS Moves
Cardiac Wire #407 October 9, 2026
A Biomarker Pair, Cardiomyopathy Care, and Better BP Management
Cardiac Wire #406 October 8, 2026
Cardiac Rehab, LAAC Data, and More Diagnostic AI
Cardiac Wire #405 October 5, 2026
Edwards’ Autus Approval, Statin Surveillance, and CV Nutrition
Cardiac Wire #404 October 1, 2026
Retatrutide’s Phase 3 TRIUMPH, Cardiac Drones, and TAVR’s MR Impact
Cardiac Wire #403 September 28, 2026
HF Clinic Disparities, GLP-1 CV Benefits Explained, and Whole Grains
Cardiac Wire #402 September 24, 2026
Bodily Aging & The Heart, Cordis’ DEB Approved, and Donor Acceptance
Cardiac Wire #401 September 21, 2026
ICDs Prevent HCM SCD, Novo’s Macrocycle Moves, and HF ACCESS
Cardiac Wire #400 September 17, 2026
Frailty in GLP-1s, PRS for CVD, and ESC Guidelines
Cardiac Wire #399 September 14, 2026
AI-ECG for MI, Dual-Energy Ablation, and AI Funding
Cardiac Wire #398 September 10, 2026
CVD Biomarker Bust, SINGLE-AF, and Several FDA Clearances
Cardiac Wire #397 September 3, 2026
AFib Procedure Efficacy, Conflicts of Interest, and Elucid’s Fundraise
Cardiac Wire #396 August 31, 2026
ACACIA-HCM’s Full Results, Mounjaro for MACE, and ESC News
Cardiac Wire #395 August 27, 2026
Cardiology’s Demographic Decline, Handheld ECG, and PH AI
Cardiac Wire #394 August 24, 2026
AI’s Context Dependence, Keep Benching, and TARTAN-HF
Cardiac Wire #393 August 20, 2026
AI Replaces Contrast, Electromechanical Waves, and AFib Measures
Cardiac Wire #392 August 17, 2026